Hemodialyzer and Hemoperfusion - Global and China Top Players Market Share and Ranking 2023
According to the research report, the global market for Hemodialyzer and Hemoperfusion should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Hemodialyzer and Hemoperfusion market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Hemodialyzer and Hemoperfusion market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Dialysis Centers grew percent to account for percent of the total market sales, and Hospitals grew percent.
Blood purification is a treatment in which a patient's blood is passed through a device in which solute (waste products, toxins) and possibly water is removed. With these advances, blood purification as a treatment for human septic shock was born.
This report studies and analyses global Hemodialyzer and Hemoperfusion status and future trends, helps the client to determine the Hemodialyzer and Hemoperfusion market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Hemodialyzer and Hemoperfusion, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Hemodialyzer and Hemoperfusion market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Hemodialyzer and Hemoperfusion sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Hemodialyzer and Hemoperfusion sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Hemodialyzer and Hemoperfusion key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Hemodialyzer and Hemoperfusion key producing regions, capacity, production, and year over year growth
(6) Hemodialyzer and Hemoperfusion industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Fresenius Medical Care
Baxter
Nipro
Asahi Kasei
Toray
B.Braun
Nikkiso
SB-KAWASUM
Medica Group
WEGO Group
Lengthen
Shanghai Peony Medical
Chengdu OCI Medical
Bain Medical Equipment
Jafron Biomedical
Kaneka Medix Corporation
CytoSorbents
Market segment by Type, covers
Hemodialyzer
Hemoperfusion
Market segment by Application, can be divided into
Dialysis Centers
Hospitals
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Hemodialyzer and Hemoperfusion product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Hemodialyzer and Hemoperfusion market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Hemodialyzer and Hemoperfusion market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Hemodialyzer and Hemoperfusion, percent & CAGR, 2018-2029
Chapter 5: Hemodialyzer and Hemoperfusion industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Hemodialyzer and Hemoperfusion Definition
1.2 Global Hemodialyzer and Hemoperfusion Market Size and Forecast
1.2.1 By Consumption Value, Global Hemodialyzer and Hemoperfusion Market Size，2018-2029
1.2.2 By Sales Quantity, Global Hemodialyzer and Hemoperfusion Market Size，2018-2029
1.2.3 Global Hemodialyzer and Hemoperfusion Average Selling Price (ASP)，2018-2029
1.3 China Hemodialyzer and Hemoperfusion Market Size and Forecast
1.3.1 By Consumption Value, China Hemodialyzer and Hemoperfusion Market Size，2018-2029
1.3.2 By Sales Quantity, China Hemodialyzer and Hemoperfusion Market Size，2018-2029
1.3.3 China Hemodialyzer and Hemoperfusion Average Selling Price (ASP)， 2018-2029
1.4 Share of China Hemodialyzer and Hemoperfusion Market with Respect to the Global Market
1.4.1 By Consumption Value, China Hemodialyzer and Hemoperfusion Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Hemodialyzer and Hemoperfusion Market Share in Global, 2018-2029
1.4.3 Hemodialyzer and Hemoperfusion Market Size: China VS Global, 2018-2029
1.5 Hemodialyzer and Hemoperfusion Market Dynamics
1.5.1 Hemodialyzer and Hemoperfusion Market Drivers
1.5.2 Hemodialyzer and Hemoperfusion Market Restraints
1.5.3 Hemodialyzer and Hemoperfusion Industry Trends
1.5.4 Hemodialyzer and Hemoperfusion Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Hemodialyzer and Hemoperfusion, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Hemodialyzer and Hemoperfusion, Global Market Share by Company, 2018-2023
2.3 Hemodialyzer and Hemoperfusion Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Hemodialyzer and Hemoperfusion Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Hemodialyzer and Hemoperfusion Concentration Ratio
2.6 Global Hemodialyzer and Hemoperfusion Mergers & Acquisitions, Expansion Plans
2.7 Global Hemodialyzer and Hemoperfusion Manufacturers Product Type
2.8 Head Office and Hemodialyzer and Hemoperfusion Production Site of Key Manufacturer
2.9 Hemodialyzer and Hemoperfusion Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Hemodialyzer and Hemoperfusion, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Hemodialyzer and Hemoperfusion, China Market Share by Company, 2018-2023
3.3 China Hemodialyzer and Hemoperfusion Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Hemodialyzer and Hemoperfusion Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Hemodialyzer and Hemoperfusion Capacity by Region
4.3 Global Hemodialyzer and Hemoperfusion Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Hemodialyzer and Hemoperfusion Production by Region, 2018-2029
4.5 Global Hemodialyzer and Hemoperfusion Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Hemodialyzer and Hemoperfusion Industry Chain
5.2 Hemodialyzer and Hemoperfusion Upstream Analysis
5.2.1 Hemodialyzer and Hemoperfusion Core Raw Materials
5.2.2 Main Manufacturers of Hemodialyzer and Hemoperfusion Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Hemodialyzer and Hemoperfusion Production Mode
5.6 Hemodialyzer and Hemoperfusion Procurement Model
5.7 Hemodialyzer and Hemoperfusion Industry Sales Model and Sales Channels
5.7.1 Hemodialyzer and Hemoperfusion Sales Model
5.7.2 Hemodialyzer and Hemoperfusion Typical Distributors
6 Sights by Type
6.1 Hemodialyzer and Hemoperfusion Classification
6.1.1 Hemodialyzer
6.1.2 Hemoperfusion
6.2 By Type, Global Hemodialyzer and Hemoperfusion Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Hemodialyzer and Hemoperfusion Consumption Value, 2018-2029
6.4 By Type, Global Hemodialyzer and Hemoperfusion Sales Quantity, 2018-2029
6.5 By Type, Global Hemodialyzer and Hemoperfusion Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Hemodialyzer and Hemoperfusion Segment by Application
7.1.1 Dialysis Centers
7.1.2 Hospitals
7.1.3 Other
7.2 By Application, Global Hemodialyzer and Hemoperfusion Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Hemodialyzer and Hemoperfusion Consumption Value, 2018-2029
7.4 By Application, Global Hemodialyzer and Hemoperfusion Sales Quantity, 2018-2029
7.5 By Application, Global Hemodialyzer and Hemoperfusion Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Hemodialyzer and Hemoperfusion Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Hemodialyzer and Hemoperfusion Consumption Value, 2018-2029
8.3 By Region, Global Hemodialyzer and Hemoperfusion Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Hemodialyzer and Hemoperfusion & Forecasts, 2018-2029
8.4.2 By Country, North America Hemodialyzer and Hemoperfusion Market Size Market Share
8.5 Europe
8.5.1 Europe Hemodialyzer and Hemoperfusion Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Hemodialyzer and Hemoperfusion Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Hemodialyzer and Hemoperfusion Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Hemodialyzer and Hemoperfusion Market Size Market Share
8.7 South America
8.7.1 South America Hemodialyzer and Hemoperfusion Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Hemodialyzer and Hemoperfusion Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Hemodialyzer and Hemoperfusion Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Hemodialyzer and Hemoperfusion Consumption Value, 2018-2029
9.3 By Country, Global Hemodialyzer and Hemoperfusion Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Hemodialyzer and Hemoperfusion Market Size, 2018-2029
9.4.2 By Type, U.S. Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Hemodialyzer and Hemoperfusion Market Size, 2018-2029
9.5.2 By Type, Europe Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Hemodialyzer and Hemoperfusion Market Size, 2018-2029
9.6.2 By Type, China Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Hemodialyzer and Hemoperfusion Market Size, 2018-2029
9.7.2 By Type, Japan Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Hemodialyzer and Hemoperfusion Market Size, 2018-2029
9.8.2 By Type, South Korea Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Hemodialyzer and Hemoperfusion Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Hemodialyzer and Hemoperfusion Market Size, 2018-2029
9.10.2 By Type, India Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Hemodialyzer and Hemoperfusion Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Fresenius Medical Care
10.1.1 Fresenius Medical Care Company Information, Head Office, Market Area, and Industry Position
10.1.2 Fresenius Medical Care Hemodialyzer and Hemoperfusion Models, Specifications, and Application
10.1.3 Fresenius Medical Care Hemodialyzer and Hemoperfusion Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Fresenius Medical Care Company Profile and Main Business
10.1.5 Fresenius Medical Care Recent Developments
10.2 Baxter
10.2.1 Baxter Company Information, Head Office, Market Area, and Industry Position
10.2.2 Baxter Hemodialyzer and Hemoperfusion Models, Specifications, and Application
10.2.3 Baxter Hemodialyzer and Hemoperfusion Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Baxter Company Profile and Main Business
10.2.5 Baxter Recent Developments
10.3 Nipro
10.3.1 Nipro Company Information, Head Office, Market Area, and Industry Position
10.3.2 Nipro Hemodialyzer and Hemoperfusion Models, Specifications, and Application
10.3.3 Nipro Hemodialyzer and Hemoperfusion Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Nipro Company Profile and Main Business
10.3.5 Nipro Recent Developments
10.4 Asahi Kasei
10.4.1 Asahi Kasei Company Information, Head Office, Market Area, and Industry Position
10.4.2 Asahi Kasei Hemodialyzer and Hemoperfusion Models, Specifications, and Application
10.4.3 Asahi Kasei Hemodialyzer and Hemoperfusion Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Asahi Kasei Company Profile and Main Business
10.4.5 Asahi Kasei Recent Developments
10.5 Toray
10.5.1 Toray Company Information, Head Office, Market Area, and Industry Position
10.5.2 Toray Hemodialyzer and Hemoperfusion Models, Specifications, and Application
10.5.3 Toray Hemodialyzer and Hemoperfusion Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Toray Company Profile and Main Business
10.5.5 Toray Recent Developments
10.6 B.Braun
10.6.1 B.Braun Company Information, Head Office, Market Area, and Industry Position
10.6.2 B.Braun Hemodialyzer and Hemoperfusion Models, Specifications, and Application
10.6.3 B.Braun Hemodialyzer and Hemoperfusion Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 B.Braun Company Profile and Main Business
10.6.5 B.Braun Recent Developments
10.7 Nikkiso
10.7.1 Nikkiso Company Information, Head Office, Market Area, and Industry Position
10.7.2 Nikkiso Hemodialyzer and Hemoperfusion Models, Specifications, and Application
10.7.3 Nikkiso Hemodialyzer and Hemoperfusion Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Nikkiso Company Profile and Main Business
10.7.5 Nikkiso Recent Developments
10.8 SB-KAWASUM
10.8.1 SB-KAWASUM Company Information, Head Office, Market Area, and Industry Position
10.8.2 SB-KAWASUM Hemodialyzer and Hemoperfusion Models, Specifications, and Application
10.8.3 SB-KAWASUM Hemodialyzer and Hemoperfusion Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 SB-KAWASUM Company Profile and Main Business
10.8.5 SB-KAWASUM Recent Developments
10.9 Medica Group
10.9.1 Medica Group Company Information, Head Office, Market Area, and Industry Position
10.9.2 Medica Group Hemodialyzer and Hemoperfusion Models, Specifications, and Application
10.9.3 Medica Group Hemodialyzer and Hemoperfusion Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Medica Group Company Profile and Main Business
10.9.5 Medica Group Recent Developments
10.10 WEGO Group
10.10.1 WEGO Group Company Information, Head Office, Market Area, and Industry Position
10.10.2 WEGO Group Hemodialyzer and Hemoperfusion Models, Specifications, and Application
10.10.3 WEGO Group Hemodialyzer and Hemoperfusion Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 WEGO Group Company Profile and Main Business
10.10.5 WEGO Group Recent Developments
10.11 Lengthen
10.11.1 Lengthen Company Information, Head Office, Market Area, and Industry Position
10.11.2 Lengthen Hemodialyzer and Hemoperfusion Models, Specifications, and Application
10.11.3 Lengthen Hemodialyzer and Hemoperfusion Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Lengthen Company Profile and Main Business
10.11.5 Lengthen Recent Developments
10.12 Shanghai Peony Medical
10.12.1 Shanghai Peony Medical Company Information, Head Office, Market Area, and Industry Position
10.12.2 Shanghai Peony Medical Hemodialyzer and Hemoperfusion Models, Specifications, and Application
10.12.3 Shanghai Peony Medical Hemodialyzer and Hemoperfusion Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Shanghai Peony Medical Company Profile and Main Business
10.12.5 Shanghai Peony Medical Recent Developments
10.13 Chengdu OCI Medical
10.13.1 Chengdu OCI Medical Company Information, Head Office, Market Area, and Industry Position
10.13.2 Chengdu OCI Medical Hemodialyzer and Hemoperfusion Models, Specifications, and Application
10.13.3 Chengdu OCI Medical Hemodialyzer and Hemoperfusion Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Chengdu OCI Medical Company Profile and Main Business
10.13.5 Chengdu OCI Medical Recent Developments
10.14 Bain Medical Equipment
10.14.1 Bain Medical Equipment Company Information, Head Office, Market Area, and Industry Position
10.14.2 Bain Medical Equipment Hemodialyzer and Hemoperfusion Models, Specifications, and Application
10.14.3 Bain Medical Equipment Hemodialyzer and Hemoperfusion Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Bain Medical Equipment Company Profile and Main Business
10.14.5 Bain Medical Equipment Recent Developments
10.15 Jafron Biomedical
10.15.1 Jafron Biomedical Company Information, Head Office, Market Area, and Industry Position
10.15.2 Jafron Biomedical Hemodialyzer and Hemoperfusion Models, Specifications, and Application
10.15.3 Jafron Biomedical Hemodialyzer and Hemoperfusion Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Jafron Biomedical Company Profile and Main Business
10.15.5 Jafron Biomedical Recent Developments
10.16 Kaneka Medix Corporation
10.16.1 Kaneka Medix Corporation Company Information, Head Office, Market Area, and Industry Position
10.16.2 Kaneka Medix Corporation Hemodialyzer and Hemoperfusion Models, Specifications, and Application
10.16.3 Kaneka Medix Corporation Hemodialyzer and Hemoperfusion Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Kaneka Medix Corporation Company Profile and Main Business
10.16.5 Kaneka Medix Corporation Recent Developments
10.17 CytoSorbents
10.17.1 CytoSorbents Company Information, Head Office, Market Area, and Industry Position
10.17.2 CytoSorbents Hemodialyzer and Hemoperfusion Models, Specifications, and Application
10.17.3 CytoSorbents Hemodialyzer and Hemoperfusion Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.17.4 CytoSorbents Company Profile and Main Business
10.17.5 CytoSorbents Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Hemodialyzer and Hemoperfusion Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Hemodialyzer and Hemoperfusion Market Restraints
Table 3. Hemodialyzer and Hemoperfusion Market Trends
Table 4. Hemodialyzer and Hemoperfusion Industry Policy
Table 5. Global Hemodialyzer and Hemoperfusion Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Hemodialyzer and Hemoperfusion Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Hemodialyzer and Hemoperfusion Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Hemodialyzer and Hemoperfusion Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Hemodialyzer and Hemoperfusion Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Hemodialyzer and Hemoperfusion Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Hemodialyzer and Hemoperfusion Mergers & Acquisitions, Expansion Plans
Table 12. Global Hemodialyzer and Hemoperfusion Manufacturers Product Type
Table 13. Head Office and Hemodialyzer and Hemoperfusion Production Site of Key Manufacturer
Table 14. Hemodialyzer and Hemoperfusion Capacity of Major Manufacturers and Future Plan
Table 15. China Hemodialyzer and Hemoperfusion Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Hemodialyzer and Hemoperfusion Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Hemodialyzer and Hemoperfusion Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Hemodialyzer and Hemoperfusion Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Hemodialyzer and Hemoperfusion Production by Region, 2018-2023, (K Units)
Table 20. Global Hemodialyzer and Hemoperfusion Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Hemodialyzer and Hemoperfusion Upstream (Raw Materials)
Table 22. Global Hemodialyzer and Hemoperfusion Typical Customers
Table 23. Hemodialyzer and Hemoperfusion Typical Distributors
Table 24. By Type, Global Hemodialyzer and Hemoperfusion Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Hemodialyzer and Hemoperfusion Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Hemodialyzer and Hemoperfusion Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Hemodialyzer and Hemoperfusion Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Hemodialyzer and Hemoperfusion Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Hemodialyzer and Hemoperfusion Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Hemodialyzer and Hemoperfusion Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Hemodialyzer and Hemoperfusion Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Hemodialyzer and Hemoperfusion Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2018-2029
Table 34. Fresenius Medical Care Company Information, Head Office, Market Area, and Industry Position
Table 35. Fresenius Medical Care Hemodialyzer and Hemoperfusion Models, Specifications, and Application
Table 36. Fresenius Medical Care Hemodialyzer and Hemoperfusion Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Fresenius Medical Care Company Profile and Main Business
Table 38. Fresenius Medical Care Recent Developments
Table 39. Baxter Company Information, Head Office, Market Area, and Industry Position
Table 40. Baxter Hemodialyzer and Hemoperfusion Models, Specifications, and Application
Table 41. Baxter Hemodialyzer and Hemoperfusion Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Baxter Company Profile and Main Business
Table 43. Baxter Recent Developments
Table 44. Nipro Company Information, Head Office, Market Area, and Industry Position
Table 45. Nipro Hemodialyzer and Hemoperfusion Models, Specifications, and Application
Table 46. Nipro Hemodialyzer and Hemoperfusion Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Nipro Company Profile and Main Business
Table 48. Nipro Recent Developments
Table 49. Asahi Kasei Company Information, Head Office, Market Area, and Industry Position
Table 50. Asahi Kasei Hemodialyzer and Hemoperfusion Models, Specifications, and Application
Table 51. Asahi Kasei Hemodialyzer and Hemoperfusion Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Asahi Kasei Company Profile and Main Business
Table 53. Asahi Kasei Recent Developments
Table 54. Toray Company Information, Head Office, Market Area, and Industry Position
Table 55. Toray Hemodialyzer and Hemoperfusion Models, Specifications, and Application
Table 56. Toray Hemodialyzer and Hemoperfusion Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Toray Company Profile and Main Business
Table 58. Toray Recent Developments
Table 59. B.Braun Company Information, Head Office, Market Area, and Industry Position
Table 60. B.Braun Hemodialyzer and Hemoperfusion Models, Specifications, and Application
Table 61. B.Braun Hemodialyzer and Hemoperfusion Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. B.Braun Company Profile and Main Business
Table 63. B.Braun Recent Developments
Table 64. Nikkiso Company Information, Head Office, Market Area, and Industry Position
Table 65. Nikkiso Hemodialyzer and Hemoperfusion Models, Specifications, and Application
Table 66. Nikkiso Hemodialyzer and Hemoperfusion Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Nikkiso Company Profile and Main Business
Table 68. Nikkiso Recent Developments
Table 69. SB-KAWASUM Company Information, Head Office, Market Area, and Industry Position
Table 70. SB-KAWASUM Hemodialyzer and Hemoperfusion Models, Specifications, and Application
Table 71. SB-KAWASUM Hemodialyzer and Hemoperfusion Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. SB-KAWASUM Company Profile and Main Business
Table 73. SB-KAWASUM Recent Developments
Table 74. Medica Group Company Information, Head Office, Market Area, and Industry Position
Table 75. Medica Group Hemodialyzer and Hemoperfusion Models, Specifications, and Application
Table 76. Medica Group Hemodialyzer and Hemoperfusion Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Medica Group Company Profile and Main Business
Table 78. Medica Group Recent Developments
Table 79. WEGO Group Company Information, Head Office, Market Area, and Industry Position
Table 80. WEGO Group Hemodialyzer and Hemoperfusion Models, Specifications, and Application
Table 81. WEGO Group Hemodialyzer and Hemoperfusion Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. WEGO Group Company Profile and Main Business
Table 83. WEGO Group Recent Developments
Table 84. Lengthen Company Information, Head Office, Market Area, and Industry Position
Table 85. Lengthen Hemodialyzer and Hemoperfusion Models, Specifications, and Application
Table 86. Lengthen Hemodialyzer and Hemoperfusion Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Lengthen Company Profile and Main Business
Table 88. Lengthen Recent Developments
Table 89. Shanghai Peony Medical Company Information, Head Office, Market Area, and Industry Position
Table 90. Shanghai Peony Medical Hemodialyzer and Hemoperfusion Models, Specifications, and Application
Table 91. Shanghai Peony Medical Hemodialyzer and Hemoperfusion Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Shanghai Peony Medical Company Profile and Main Business
Table 93. Shanghai Peony Medical Recent Developments
Table 94. Chengdu OCI Medical Company Information, Head Office, Market Area, and Industry Position
Table 95. Chengdu OCI Medical Hemodialyzer and Hemoperfusion Models, Specifications, and Application
Table 96. Chengdu OCI Medical Hemodialyzer and Hemoperfusion Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Chengdu OCI Medical Company Profile and Main Business
Table 98. Chengdu OCI Medical Recent Developments
Table 99. Bain Medical Equipment Company Information, Head Office, Market Area, and Industry Position
Table 100. Bain Medical Equipment Hemodialyzer and Hemoperfusion Models, Specifications, and Application
Table 101. Bain Medical Equipment Hemodialyzer and Hemoperfusion Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Bain Medical Equipment Company Profile and Main Business
Table 103. Bain Medical Equipment Recent Developments
Table 104. Jafron Biomedical Company Information, Head Office, Market Area, and Industry Position
Table 105. Jafron Biomedical Hemodialyzer and Hemoperfusion Models, Specifications, and Application
Table 106. Jafron Biomedical Hemodialyzer and Hemoperfusion Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Jafron Biomedical Company Profile and Main Business
Table 108. Jafron Biomedical Recent Developments
Table 109. Kaneka Medix Corporation Company Information, Head Office, Market Area, and Industry Position
Table 110. Kaneka Medix Corporation Hemodialyzer and Hemoperfusion Models, Specifications, and Application
Table 111. Kaneka Medix Corporation Hemodialyzer and Hemoperfusion Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Kaneka Medix Corporation Company Profile and Main Business
Table 113. Kaneka Medix Corporation Recent Developments
Table 114. CytoSorbents Company Information, Head Office, Market Area, and Industry Position
Table 115. CytoSorbents Hemodialyzer and Hemoperfusion Models, Specifications, and Application
Table 116. CytoSorbents Hemodialyzer and Hemoperfusion Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. CytoSorbents Company Profile and Main Business
Table 118. CytoSorbents Recent Developments
List of Figures
Figure 1. Hemodialyzer and Hemoperfusion Picture
Figure 2. Global Hemodialyzer and Hemoperfusion Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Hemodialyzer and Hemoperfusion Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Hemodialyzer and Hemoperfusion Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Hemodialyzer and Hemoperfusion Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Hemodialyzer and Hemoperfusion Sales Quantity (K Units) & (2018-2029)
Figure 7. China Hemodialyzer and Hemoperfusion Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Hemodialyzer and Hemoperfusion Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Hemodialyzer and Hemoperfusion Market Share of Global, 2018-2029
Figure 10. Global Hemodialyzer and Hemoperfusion Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Hemodialyzer and Hemoperfusion Key Participants, Market Share, 2022
Figure 12. Global Hemodialyzer and Hemoperfusion Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Hemodialyzer and Hemoperfusion Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Hemodialyzer and Hemoperfusion Production Market Share & Forecast by Region, 2018-2029
Figure 15. Hemodialyzer and Hemoperfusion Industry Chain
Figure 16. Hemodialyzer and Hemoperfusion Procurement Model
Figure 17. Hemodialyzer and Hemoperfusion Sales Model
Figure 18. Hemodialyzer and Hemoperfusion Sales Channels, Direct Sales, and Distribution
Figure 19. Hemodialyzer
Figure 20. Hemoperfusion
Figure 21. By Type, Global Hemodialyzer and Hemoperfusion Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Hemodialyzer and Hemoperfusion Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Hemodialyzer and Hemoperfusion Sales Quantity, 2018-2029, (K Units)
Figure 24. By Type, Global Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Hemodialyzer and Hemoperfusion Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 26. Dialysis Centers
Figure 27. Hospitals
Figure 28. Other
Figure 29. By Application, Global Hemodialyzer and Hemoperfusion Consumption Value, 2018-2029, US$ Million
Figure 30. By Application, Global Hemodialyzer and Hemoperfusion Consumption Value Market Share, 2018-2029
Figure 31. By Application, Global Hemodialyzer and Hemoperfusion Sales Quantity, 2018-2029, (K Units)
Figure 32. By Application, Global Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2018-2029
Figure 33. By Application, Global Hemodialyzer and Hemoperfusion Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 34. By Region, Global Hemodialyzer and Hemoperfusion Consumption Value Market Share, 2018-2029
Figure 35. By Region, Global Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2018-2029
Figure 36. North America Hemodialyzer and Hemoperfusion Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 37. By Country, North America Hemodialyzer and Hemoperfusion Consumption Value Market Share, 2022
Figure 38. Europe Hemodialyzer and Hemoperfusion Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, Europe Hemodialyzer and Hemoperfusion Consumption Value Market Share, 2022
Figure 40. Asia Pacific Hemodialyzer and Hemoperfusion Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country/Region, Asia Pacific Hemodialyzer and Hemoperfusion Consumption Value Market Share, 2022
Figure 42. South America Hemodialyzer and Hemoperfusion Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, South America Hemodialyzer and Hemoperfusion Consumption Value Market Share, 2022
Figure 44. Middle East & Africa Hemodialyzer and Hemoperfusion Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. U.S. Hemodialyzer and Hemoperfusion Sales Quantity, 2018-2029, (K Units)
Figure 46. By Type, U.S. Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
Figure 47. By Application, U.S. Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
Figure 48. Europe Hemodialyzer and Hemoperfusion Sales Quantity, 2018-2029, (K Units)
Figure 49. By Type, Europe Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, Europe Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
Figure 51. China Hemodialyzer and Hemoperfusion Sales Quantity, 2018-2029, (K Units)
Figure 52. By Type, China Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, China Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
Figure 54. Japan Hemodialyzer and Hemoperfusion Sales Quantity, 2018-2029, (K Units)
Figure 55. By Type, Japan Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, Japan Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
Figure 57. South Korea Hemodialyzer and Hemoperfusion Sales Quantity, 2018-2029, (K Units)
Figure 58. By Type, South Korea Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, South Korea Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
Figure 60. Southeast Asia Hemodialyzer and Hemoperfusion Sales Quantity, 2018-2029, (K Units)
Figure 61. By Type, Southeast Asia Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, Southeast Asia Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
Figure 63. India Hemodialyzer and Hemoperfusion Sales Quantity, 2018-2029, (K Units)
Figure 64. By Type, India Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, India Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
Figure 66. Middle East & Africa Hemodialyzer and Hemoperfusion Sales Quantity, 2018-2029, (K Units)
Figure 67. By Type, Middle East & Africa Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, Middle East & Africa Hemodialyzer and Hemoperfusion Sales Quantity Market Share, 2022 VS 2029
Figure 69. Research Methodology
Figure 70. Breakdown of Primary Interviews
Figure 71. Bottom-up and Top-down Approaches
Figure 72. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|